Condition: Alport Syndrome · Sponsor: Bayer
Alport syndrome (AS) is a rare genetic condition that causes kidney disease, hearing loss, and eye abnormalities that occur due to changes in specific genes (COL4A3, COL4A4, and COL4A5). These genes help in producing an important protein called collagen. People with AS have a high risk of developing chronic kidney disease (CKD), a condition in which there is progressive loss in kidney function over time. The kidneys soon lose their ability to remove waste products from the body properly, resulting in end-stage kidney disease. A common sign of decreasing kidney function is the presence of excess protein in the urine that is not usually found with healthy kidneys. This condition is known as proteinuria. The study drug, BAY 3401016 (a monoclonal antibody), is a type of medicine that blocks a protein called Semaphorin 3A (Sema3A), which is thought to be involved in causing kidney damage in AS. By blocking the action of the Sema3A protein, BAY 3401016 may prevent proteinuria and slow down the loss in kidney function due to AS. The main purpose of this study is to learn more about how well BAY 3401016 works in slowing down the loss in kidney function in adults with a rapidly progressing AS.
This description comes directly from the study's public registry record.
Bayer Clinical Trials Contact · (+)1-888-84 22937 · clinical-trials-contact@bayer.com
Always discuss trial participation with your own doctor first.
| Nephrology Clinic at The Kirklin Clinic of UAB Hospital | Birmingham, Alabama, United States | Recruiting |
| The Peggy and Harold Katz Family Drug Discovery Center - Nephrology | Miami, Florida, United States | Not Yet Recruiting |
| Center for Advanced Pediatrics - Nephrology | Atlanta, Georgia, United States | Not Yet Recruiting |
| Cardio Renal Institute | Chubbuck, Idaho, United States | Recruiting |
| Tufts Medical Center | Nephrology Department | Boston, Massachusetts, United States | Recruiting |
| Renal Disease Research Institute | Landry | Dallas, Texas, United States | Recruiting |
| Clinica de Nefrologia, Urologia y Enfermedades Cardiovasculares S.A. | Santa Fe, Santa Fe Province, Argentina | Recruiting |
| Hospital Británico | Buenos Aires, Argentina | Recruiting |
| Centro de Educacion Medica e Investigaciones Clinicas "Norberto Quirno" (CEMIC) | Buenos Aires, Argentina | Recruiting |
| Centro de Rehabilitacion Cardiovascular | San Luis, Argentina | San Luis, Argentina | Recruiting |
| St Joseph's Healthcare Hamilton | Cardiology | Hamilton, Ontario, Canada | Recruiting |
| University Hospital | Nephrology | London, Ontario, Canada | Not Yet Recruiting |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07211685